Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry

PURPOSE: Immediate and proper implementation of a new and more potent therapy is important to ensure that the patient achieves the best possible outcome. This study aimed to examine whether the real-world overall survival (OS) has improved in patients with human epidermal growth factor receptor 2-po...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: Ibragimova, Khava I. E., Geurts, Sandra M. E., Croes, Sander, Erdkamp, Frans, Heijns, Joan B., Tol, Jolien, Vriens, Birgit E. P. J., Aaldering, Kirsten N. A., Dercksen, Marcus W., Pepels, Manon J. A. E., Peters, Natascha A. J. B., van de Winkel, Linda, Tilli, Dominique J. P., Vriens, Ingeborg J. H., de Boer, Maaike, Tjan-Heijnen, Vivianne C. G.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2021
Assuntos:
Epidemiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8260428/
https://ncbi.nlm.nih.gov/pubmed/33743103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-021-06178-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados